Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,699Revenue $M96.5Net Margin (%)-118.5Z-Score3.5
Enterprise Value $M3,774EPS $-0.3Operating Margin %-82.5F-Score3
P/E(ttm))0Cash Flow Per Share $-0.0Pre-tax Margin (%)-108.0Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %4.4Quick Ratio2.2Cash flow > EarningsY
Price/Sales38.95-y EBITDA Growth Rate %27.0Current Ratio2.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-8.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-13.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M414ROI % (ttm)-1.2Gross Margin Increase y-yN

Gurus Latest Trades with OPK

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPKGeorge Soros 2014-03-31 Add0.06%$7.58 - $9.96
($8.75)
$ 8.942%Add 76.98%1,494,800
OPKGeorge Soros 2013-09-30 Buy 0.07%$7.18 - $9.24
($8.02)
$ 8.9412%New holding, 745000 sh.745,000
OPKMario Gabelli 2011-03-31 Reduce$3.48 - $4.83
($4.01)
$ 8.94123%Reduce -90.58%15,000
OPKMario Gabelli 2010-09-30 Add$2.07 - $2.6
($2.31)
$ 8.94287%Add 962%159,300
OPKMario Gabelli 2010-06-30 Reduce$1.87 - $2.55
($2.11)
$ 8.94324%Reduce -90%15,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPK is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
OPK George Soros 2014-03-311,494,8000.360.14+76.98%
OPK Mario Gabelli 2014-03-3115,00000
Premium Most recent portfolio changes are included for Premium Members only!


OPK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-25Buy36,000$9.01-0.78view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-23Buy10,000$8.90.45view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-22Buy30,000$8.663.23view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-17Buy40,000$8.633.59view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-16Buy20,000$8.762.05view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-15Buy26,000$8.732.41view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-14Buy20,000$8.910.34view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-10Buy20,000$8.791.71view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-08Buy30,000$8.584.2view
FROST PHILLIP MD ET ALCEO & Chairman, 10% Owner 2014-07-07Buy27,000$8.791.71view

Press Releases about OPK :

    Quarterly/Annual Reports about OPK:

    News about OPK:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: OPK, LJPC, SFNC, HAFC, TUBE Jul 28 2014 
    Weekly CEO Buys Highlight: OPK, QTET, MIC, FAST, OCRX Jul 21 2014 
    Top Insider Buys Highlight: Opko Health Inc. Jul 17 2014 
    Weekly CEO Buys Highlight: OPK, GBIM, RICK Jul 15 2014 
    Weekly CEO Buys Highlight: NEP, OPK, EXXI, ISTR Jul 07 2014 
    Weekly CEO Buys Highlight: OPK, FELP, FULL, ENBL, TLYS Jun 27 2014 
    Weekly CEO Buys Highlight: LGCY, OPK, FELP, FULL, ENH Jun 23 2014 
    OPKO CEO Is Building A Pharma Powerhouse And Continuously Buying Shares Jun 20 2014 
    Weekly CEO Buys Highlight: ENH, OPK, JIVE, CONE Jun 16 2014 
    Weekly CEO Buys Highlight: KMI, PBFX, OPK, AOL, UAM May 17 2014 

    More From Other Websites
    [video] What's coming in biotech? Jul 23 2014
    OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE Jul 22 2014
    OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE Jul 22 2014
    [video] Pro's favorite insider plays: GE, DKS & OPK Jul 11 2014
    Cramer's Lightning Round - I Like Nike (7/10/14) Jul 11 2014
    Today's Top Performers In Health Services Jul 10 2014
    OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug... Jul 09 2014
    OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug... Jul 09 2014
    Nobel Laureate Roger Kornberg to Chair New ChromaDex Scientific Advisory Board Jul 08 2014
    OPKO Granted Patent from European Patent Office for Lagova™ Jun 27 2014
    OPKO Granted Patent from European Patent Office for Lagova™ Jun 27 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 24 2014
    OPKO CEO Is Building A Pharma Powerhouse And Continuously Buying Shares Jun 20 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities Jun 20 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders,... Jun 17 2014
    Call buyers bet on Opko rebound Jun 05 2014
    OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 03 2014
    OPKO Health to Present at the Jefferies 2014 Global Healthcare Conference May 28 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide